Fitzroy Harbour, Canada

Gordon Bruce Collier

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 134(Granted Patents)


Location History:

  • Fitzroy Harbor, CA (2016)
  • Fitzroy Harbour, CA (2011 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Gordon Bruce Collier: Innovator in Coagulation Assays

Introduction: Gordon Bruce Collier is a notable inventor residing in Fitzroy Harbour, Canada, recognized for his contributions to the field of biochemistry and diagnostic technology. With a remarkable portfolio comprising 22 patents, Collier has significantly advanced methods for performing coagulation assays, showcasing his dedication to innovation and practical applications in healthcare.

Latest Patents: Among Collier's latest patents is a groundbreaking invention involving ellagic acid formulations for use in coagulation assays. This patent outlines a highly stable composition that not only allows for long-term storage but also reduces the assay time significantly. The innovative method includes solubilizing ellagic acid using substances such as sodium hydroxide, methanol, and polyether compounds like polyethylene glycol, polyethylene oxide, or polyoxyethylene, alongside a cyclodextrin guest-host complex. This advancement holds promise for enhancing the efficiency and reliability of coagulation tests.

Career Highlights: Throughout his career, Gordon Bruce Collier has been associated with prominent companies in the biomedical sector. Notably, he has worked for Abbott Point of Care Inc. and Ibis Biosciences, Inc., where he contributed his expertise in developing medical and diagnostic technologies. His work continues to influence practices in the field and underscores his role as a leader in innovation.

Collaborations: Collaboration has been a vital aspect of Collier's journey as an inventor. He has worked alongside skilled professionals such as Jason Andrew MacLeod and Attila Csaba Nemeth. These partnerships have fostered a creative environment that has been instrumental in his endeavors to push the boundaries of scientific discovery.

Conclusion: Gordon Bruce Collier exemplifies the spirit of innovation through his numerous patents and contributions to the field of coagulation assays. With a commitment to improving diagnostic accuracy and efficiency, Collier's work remains at the forefront of medical technology advancements, making him a valuable asset to the industry. As he continues to explore new ideas and methodologies, his impact on healthcare and biochemistry will undoubtedly endure.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…